Gadoversetamide
From Wikipedia, the free encyclopedia
 |
|
|
Gadoversetamide
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | V08 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H34GdN5O10 |
| Mol. mass | 661.77 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | Nil |
| Metabolism | Nil |
| Half life | 80 to 120 minutes |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Intravenous |
Gadoversetamide is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver.[1] It is marketed under the trade name OptiMARK.
[edit] Notes
- ^ Gadoversetamide Drug Information. Drugs.com (March 20, 2000). Retrieved on 2007-03-23.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
